A seventh Victorian patient is in hospital with acute liver failure after a second injection of a vial bought for weight loss and labelled retatrutide, an experimental obesity peptide that no drug regulator worldwide has approved for sale. Liver transplant specialist Dr Marie Sinclair confirmed the case on 24 August 2026, saying the injury appeared within weeks of the dose and matched the six preceding hospitalisations she has treated since January (ABC News reporting on the seventh liver-toxicity case).
No approved retatrutide formulation exists anywhere. The seven hospitalised Victorians had no batch number to trace and no manufacturer obligated to issue a recall. No prescriber monitored their liver enzymes between doses. They obtained vials through social-media advertisements and peer contacts marketing the compound for fat loss and muscle growth, entirely outside pharmaceutical supply chains. For a broader look at the safety evidence behind compounds like this, see are research peptides safe.
Victoria's Chief Health Officer Dr Caroline McElnay issued a formal alert on 19 June after the first six cases, documenting jaundice, dark urine, abnormal bruising, and transaminitis with possible coagulopathy (Victorian Department of Health alert on retatrutide toxicity). The seventh case, confirmed two months later, shifted the clinical question from scattered adverse reactions toward a possible single-source contamination event.
Figure 1: Schematic of the Victoria retatrutide adverse-event cluster, tracing social-marketplace vials, unmonitored self-injection, liver enzyme rise, hospitalisation, and open contaminant testing.
A batch problem confined to Victoria
Professor Robyn Langham, the Therapeutic Goods Administration's chief medical advisor, told the ABC that "the localised nature" of the injuries suggested "a batch problem." The cluster had not replicated in other states. Sinclair called the contamination theory "purely a hypothesis at this stage" and confirmed she had commissioned laboratory testing of vials used by the affected patients. Canberra Health Services told the ABC it had detected liver damage from products sold as retatrutide but declined to specify case numbers. Queensland Health and NSW Health reported no cases.
The alert does not reach the buyer
The affected Victorians bought their injections from Facebook Marketplace listings and gym-community contacts, or through social-media accounts promoting "reta" for recovery. Professor Langham said the TGA was most concerned about adolescents purchasing and injecting these products after seeing social-media promotions. The counterfeit vials, she said, "have not been tested in clinical trials, they have not been tested in terms of their manufacturing, and they've not been tested for their safety."
The Victorian Health Department publishes its alert in English on a government website. The actual purchase happens in cash from a beautician, through a group chat, or via a marketplace listing labelled "research chemical, not for human use." The warning format does not match the purchase channel, and the populations most exposed to these vials are the least likely to encounter a .gov.au health advisory.
Leeder Analytical, testing at the request of the ABC and the University of Queensland, found two of three counterfeit retatrutide vials contained concentrations far exceeding the label, while one contained less than advertised. Sinclair cautioned that even a positive purity result offers limited reassurance: "All that they know from this testing is that there is some retatrutide in their vials. It doesn't actually tell them if there's any other contaminants or any other drugs or medications that could be mixed with them" (ABC News analysis of black-market peptide dosing). Our explainer on peptide testing details what consumer-grade assays can and cannot detect in unregulated vials.
Sinclair is waiting on laboratory results from the vials linked to the seventh patient. No contaminant has been publicly identified. Until those results return, the batch hypothesis remains unconfirmed, and the seven hospitalised Victorians remain the only documented evidence that something in these vials is destroying livers.
